Nerida ScottVP, Head of Innovation EMEA at Johnson & JohnsonSpeaker
Profile
Nerida Scott is the Head of Innovation in EMEA, located at the Innovation Centre in London, UK. In this role, Nerida oversees the EMEA portfolio of collaborations, co-investments (JJDC), and company incubations (JLABS) to construct, prioritize and advance early external innovation opportunities for Johnson & Johnson. With her team in EMEA, she identifies and accelerates science and technology outside the company in areas of strategic value to medical technology and innovative medicines, exploring new models to support external R&D collaboration and grow early-stage innovation networks. She works with diverse partners in the life sciences ecosystem, including academia, SMEs, venture capital, entrepreneurs, medical charities, NGOs and governmental organizations.
Before joining Johnson & Johnson in 2015, Nerida was Director for Business Development & Licensing and Executive Team member at Vernalis PLC, a UK biotech company with US commercial activities, responsible for transactions from evaluation through negotiation to closing. Before that, Nerida worked in business development at RiboTargets, a biotech building on Nobel Prize-winning science from the lab of Venki Ramakrishnan. Her experience also includes The Boston Consulting Group in London, where she was a project leader providing strategic counsel to clients on M&A opportunities, R&D, manufacturing, and business strategies. Nerida has a broad background in operational and commercial activities with over 25 years of diverse business and transaction experience, including acquisitions and divestments in the pharmaceutical and healthcare industries.
Agenda Sessions
Market spotlight: How is innovation from China and Asia reshaping global biopharma?
, 09:30View Session